Higher Hemoglobin Targets for Chronic Kidney Disease Linked to Heart Complications


Both the Cardiovascular Risk Reduction by Early Anemia Treatment with Epoetin Beta (CREATE) trial and the Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR) trial suggested caution in the full correction of anemia. Results of the studies were published in the Nov. 16 issue of The /New England Journal of Medicine.